Albireo Pharma, Inc.
Doing business as (A Development Stage Company)
- UEI
- GQGYRLY83ZA1
- CAGE
- 6JKY0
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- ipsen.com
- Founded
- 1929
- Employees
- 5K-10K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Rhythm Pharmaceuticals, Inc. | Boston, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Sanofi Genzyme | Cambridge, MA | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Albireo Pharma, Inc. - doing business as (A Development Stage Company) is a for-profit corporate entity that manufactures goods, specifically pharmaceuticals and drugs. According to its website, Ipsen is a global biopharmaceutical company specializing in oncology, rare diseases, and neuroscience, developing innovative medicines to improve patient health outcomes worldwide.
Albireo Pharma holds multiple federal contract IDVs with the Department of Veterans Affairs (VA) to provide pharmaceuticals and drugs. This includes a $883,061.15 Blanket Purchase Agreement (BPA) awarded by the VA National Acquisition Center against the Pharmaceuticals and Drugs GSA Schedule for the drug Bylvay, used to treat the rare disease progressive familial intrahepatic cholestasis. The BPA facilitates task order delivery of Bylvay to VA medical centers nationwide from April 2022 through March 2025. Albireo Pharma also holds a $225,000 multiple award Federal Supply Schedule contract with the VA Veterans Integrated Service Network 12 under the Pharmaceuticals and Drugs schedule from March 2022 to March 2027. This allows the VA to order various pharmaceuticals beyond just Bylvay during the period of performance. Additionally, a $25,000 interim agreement was awarded in October 2021 to bridge a gap in the supply schedule.
Quick answers
Is Albireo Pharma, Inc. registered in SAM.gov?
Albireo Pharma, Inc.'s SAM.gov registration expired on October 3, 2026.
Which contract vehicles does Albireo Pharma, Inc. hold?
Albireo Pharma, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Albireo Pharma, Inc.'s most recent federal award?
Albireo Pharma, Inc.'s most recent federal grant award is Development of novel and stable glucagon formulations for closed loop systems (R43DK096602), from National Institutes of Health, on September 19, 2012.
On GovTribe
See Albireo Pharma, Inc.'s full federal record
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors